The Discounted Cash Flow (DCF) valuation of Intercept Pharmaceuticals Inc (ICPT) is (184.13) USD. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on DCF is -1069.1%.
Based on the latest price of 19.00 USD and our DCF valuation, Intercept Pharmaceuticals Inc (ICPT) is a sell. selling ICPT stocks now will result in a potential gain of 1069.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.0% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (627.57) - (111.42) | (184.13) |
| Upside | -3403.0% - -686.4% | -1069.1% |